DR. JEFFREY M STEWART MD NPI 1982715892

NPI Details

DR. Jeffrey M Stewart, MD is a hematology and oncology internal medicine in Middletown, NY with 38 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Jeffrey M Stewart, MD NPI is 1982715892. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE
Graduation Year:1988

The provider's business location address is:

185 RYKOWSKI LN
MIDDLETOWN, NY
ZIP 10941-055
Phone: (845) 703-6999
Fax: (845) 703-6297

The NPI 1982715892 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Liver enzyme (sgot), level (HCPCS:84450)
• Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)
• Albumin (protein) level (HCPCS:82040)
• Bilirubin level, total (HCPCS:82247)
• Total protein level, blood (HCPCS:84155)
• Liver enzyme (sgpt), level (HCPCS:84460)
• Phosphatase (enzyme) level, alkaline (HCPCS:84075)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg (HCPCS:Q5111)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Blood test, clotting time (HCPCS:85610)
• Folic acid level, serum (HCPCS:82746)
• Anticoagulant management of patient taking warfarin (HCPCS:93793)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Unclassified drugs (HCPCS:J3490)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Red blood count, automated test (HCPCS:85045)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Magnesium level (HCPCS:83735)
• Uric acid level, blood (HCPCS:84550)
• Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous (HCPCS:G0328)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Troponin (protein) analysis, quantitative (HCPCS:84484)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Automated urinalysis test (HCPCS:81003)
• Analysis for antibody borrelia burgdorferi (lyme disease bacteria) (HCPCS:86618)

The enumeration date for this NPI number is 8/31/2006 and was last updated on 10/16/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.